High Symptom Improvement and Local Tumor Control Using Stereotactic Radiotherapy when Given Early After Diagnosis of Meningioma. A Multicentre Study

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2012 Sep 11

PMID 22961046

Citations 11

Authors

I Compter

K Zaugg

R M A Houben

J T A Dings

G Bosmans

C Buescher

M M H M E Anten

B G Baumert

Affiliations

Soon will be listed here.

Abstract

Purpose: The goal of the present study was to analyze long-term results of fractionated stereotactic radiotherapy (SRT) in patients with a meningioma.

Methods And Materials: A total of 72 patients treated between 1996 and 2008 in MAASTRO clinic (n = 45) and University Hospital Zurich (n = 27) were included. SRT was given as primary treatment (n = 46), postoperatively (n = 19) or at recurrence (n = 7); 49 tumours (68%) were located in the skull base. Median total dose was 54 Gy.

Results: Median follow-up was 4.13 years (range 0.66-11 years). The 3- and 5-year overall survival were 92 and 79% for grade 0 and I meningioma. Progression-free survival for grade 0 and I was 95% at 3 and 5 years, and 40% for grade II and III at 3 years. In 98.4% of patients, clinical symptoms were stable or improved. The majority of symptoms improved within 24 months after SRT. Local control is significantly better if patients are irradiated immediately after diagnosis compared to a watchful waiting policy (p = 0.017). Grade IV toxicity was low (4.2%, n = 3)

Conclusion: SRT is an effective treatment with high local and clinical control. Early SRT resulted in better outcome than late treatment at progression.

Citing Articles

A single center, inter-observer evaluation of vestibular schwannoma stereotactic radiosurgery and its dosimetric impact.

Perez-Calatayud M, Menendez A, Lliso F, Carmona V, Conde A, Celada F J Radiosurg SBRT. 2024; 9(2):113-120.

PMID: 39087056 PMC: 11288650.

High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial).

Zegers C, Swinnen A, Roumen C, Hoffmann A, Troost E, van Asch C Trials. 2024; 25(1):334.

PMID: 38773643 PMC: 11106873. DOI: 10.1186/s13063-024-08168-9.

Meningioma involving the superior sagittal sinus: long-term outcome after robotic radiosurgery in primary and recurrent situation.

Schmutzer M, Skrap B, Thorsteinsdottir J, Furweger C, Muacevic A, Schichor C Front Oncol. 2023; 13:1206059.

PMID: 37496660 PMC: 10367096. DOI: 10.3389/fonc.2023.1206059.

Surgical and Functional Outcome after Resection of 64 Petroclival Meningiomas.

Wagner A, Alraun M, Kahlig V, Dorier A, Aftahy A, Bernhardt D Cancers (Basel). 2022; 14(18).

PMID: 36139677 PMC: 9496694. DOI: 10.3390/cancers14184517.

High-precision radiotherapy for meningiomas : Long-term results and patient-reported outcome (PRO).

Kessel K, Fischer H, Oechnser M, Zimmer C, Meyer B, Combs S Strahlenther Onkol. 2017; 193(11):921-930.

PMID: 28620750 DOI: 10.1007/s00066-017-1156-3.

References

Mirimanoff R, Dosoretz D, Linggood R, Ojemann R, Martuza R . Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985; 62(1):18-24. DOI: 10.3171/jns.1985.62.1.0018. View

Stafford S, Perry A, Suman V, Meyer F, Scheithauer B, Lohse C . Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998; 73(10):936-42. DOI: 10.4065/73.10.936. View

Baumert B, Egli P, Studer S, Dehing C, Bernard Davis J . Repositioning accuracy of fractionated stereotactic irradiation: assessment of isocentre alignment for different dental fixations by using sequential CT scanning. Radiother Oncol. 2005; 74(1):61-6. DOI: 10.1016/j.radonc.2004.08.002. View

Wiggenraad R, Petoukhova A, Versluis L, van Santvoort J . Stereotactic radiotherapy of intracranial tumors: a comparison of intensity-modulated radiotherapy and dynamic conformal arc. Int J Radiat Oncol Biol Phys. 2009; 74(4):1018-26. DOI: 10.1016/j.ijrobp.2008.09.057. View

Torres R, Frighetto L, De Salles A, Goss B, Medin P, Solberg T . Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurg Focus. 2005; 14(5):e5. DOI: 10.3171/foc.2003.14.5.6. View

DeVries A, Munzenrider J, Hedley-Whyte T, Hug E . [The role of radiotherapy in the treatment of malignant meningiomas]. Strahlenther Onkol. 1999; 175(2):62-7. DOI: 10.1007/BF02753844. View

Baumert B, Villa S, Studer G, Mirimanoff R, Bernard Davis J, Landau K . Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol. 2004; 72(2):169-74. DOI: 10.1016/j.radonc.2004.04.008. View

Selch M, Ahn E, Laskari A, Lee S, Agazaryan N, Solberg T . Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2004; 59(1):101-11. DOI: 10.1016/j.ijrobp.2003.09.003. View

Duchstein S, Gademann G, Peters B . [Early and late effects of local high dose radiotherapy of the brain on memory and attention]. Strahlenther Onkol. 2003; 179(7):441-51. DOI: 10.1007/s00066-003-1034-z. View

10.

Theelen A, Martens J, Bosmans G, Houben R, Jager J, Rutten I . Relocatable fixation systems in intracranial stereotactic radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol. 2011; 188(1):84-90. DOI: 10.1007/s00066-011-0018-7. View

11.

Hamm K, Henzel M, Gross M, Surber G, Kleinert G, Engenhart-Cabillic R . Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas. Zentralbl Neurochir. 2008; 69(1):14-21. DOI: 10.1055/s-2007-992138. View

12.

Alheit H, Dornfeld S, Dawel M, Alheit M, Henzel B, Steckler K . Patient position reproducibility in fractionated stereotactically guided conformal radiotherapy using the BrainLab mask system. Strahlenther Onkol. 2001; 177(5):264-8. DOI: 10.1007/pl00002407. View

13.

Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J . Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature. Strahlenther Onkol. 2006; 182(11):635-40. DOI: 10.1007/s00066-006-1548-2. View

14.

Jalali R, Loughrey C, Baumert B, Perks J, Warrington A, Traish D . High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol). 2002; 14(2):103-9. DOI: 10.1053/clon.2001.0040. View

15.

De Ruysscher D, Severin D, Barnes E, Baumann M, Bristow R, Gregoire V . First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II. Radiother Oncol. 2010; 97(1):36-9. DOI: 10.1016/j.radonc.2010.03.012. View

16.

Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I . High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol. 2001; 19(15):3547-53. DOI: 10.1200/JCO.2001.19.15.3547. View

17.

Henzel M, Gross M, Hamm K, Surber G, Kleinert G, Failing T . Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol. 2006; 182(7):382-8. DOI: 10.1007/s00066-006-1535-7. View

18.

Sindou M, Wydh E, Jouanneau E, Nebbal M, Lieutaud T . Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone. J Neurosurg. 2007; 107(5):937-44. DOI: 10.3171/JNS-07/11/0937. View

19.

Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I . Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery. 2005; 57(5):873-86. DOI: 10.1227/01.neu.0000179924.76551.cd. View

20.

Pourel N, Auque J, Bracard S, Hoffstetter S, Luporsi E, Vignaud J . Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience. Radiother Oncol. 2001; 61(1):65-70. DOI: 10.1016/s0167-8140(01)00391-7. View